Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Translational Andrology and Urology|June 15, 2026
Analysis of real-world re-induction outcomes with nadofaragene firadenovec in patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancerChad Reichard, Andrew Trainer, Katie Grant, et al.
Urologic Oncology|July 31, 2017
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim resultsVignesh T Packiam, Donald L Lamm, Daniel A Barocas, et al.
The Journal of Urology|January 24, 2018
WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaPeter Gilling, Neil Barber, Mohamed Bidair, et al.
The Canadian Journal of Urology|February 18, 2020
Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trialPeter Gilling, Neil Barber, Mohamed Bidair, et al.
Advances in Therapy|April 28, 2019
Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements SustainedPeter Gilling, Neil Barber, Mohamed Bidair, et al.
BJU International|June 5, 2018
Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trialMark Plante, Peter Gilling, Neil Barber, et al.
Urology|May 7, 2019
Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year ResultsNaeem Bhojani, Mohamed Bidair, Kevin C Zorn, et al.
BJU International|April 26, 2018
WATER II (80-150 mL) procedural outcomesMihir Desai, Mo Bidair, Naeem Bhojani, et al.
BJUI Compass|April 27, 2022
Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial resultsKevin C Zorn, Mohamed Bidair, Andrew Trainer, et al.
BJU International|February 9, 2019
Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trialMihir Desai, Mo Bidair, Kevin C Zorn, et al.
Pageof 2